Biota, Inc. Announces Preliminary Phase III Prophylaxis Trial Results for CS-8959
6/27/2011 10:00:19 AM
MELBOURNE, Australia--(BUSINESS WIRE)--Dr Seizaburo Kashiwagi presented the preliminary data from an influenza Phase III prophylaxis study conducted during the 2009/2010 pandemic flu season in Japan. The SHIELD study (Study of Household Influenza prophylaxis Effect of Long-acting anti-influenza Drug) presentation was made at the 59th Annual Meeting of the Japanese Society of Chemotherapy.
comments powered by